Concepedia

Peter Higgins

PH

Statistics

Publications

192

Citations

18.9K

H-Index

74

Active since

1993

Affiliations

University of Michigan(Current)

Michigan Medicine

VA Center for Clinical Management Research

Icahn School of Medicine at Mount Sinai

University of North Carolina at Chapel Hill

Peter Higgins is an author at University of Michigan specializing in inflammatory bowel disease, medicine, and gastrointestinal inflammation.

Publications per year

1993–2025

192

Publications

192

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky et al. · Gut · 2012 · 1.5K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Statins and the Risk of Colorectal Cancer

Jenny N. Poynter, Stephen B. Gruber, Peter Higgins et al. · New England Journal of Medicine · 2005 · 826 citations

Medicine, Oncology, Pharmacology +12

A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

B. Joseph Elmunzer, James M. Scheiman, Glen A. Lehman et al. · New England Journal of Medicine · 2012 · 726 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

A Primer on Effectiveness and Efficacy Trials

Amit G. Singal, Peter Higgins, Akbar K. Waljee · Clinical and Translational Gastroenterology · 2014 · 705 citations · Full text

Public Health, Biostatistics, Comparative Effectiveness Research +16

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou et al. · The Lancet · 2022 · 597 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +10

1–5 of 192